Cargando…
A gene expression signature predicts recurrence-free survival in meningioma
BACKGROUND: Meningioma is the most common primary brain tumor and has a variable risk of local recurrence. While World Health Organization (WHO) grade generally correlates with recurrence, there is substantial within-grade variation of recurrence risk. Current risk stratification does not accurately...
Autores principales: | Olar, Adriana, Goodman, Lindsey D., Wani, Khalida M., Boehling, Nicholas S., Sharma, Devi S., Mody, Reema R., Gumin, Joy, Claus, Elizabeth B., Lang, Frederick F., Cloughesy, Timothy F., Lai, Albert, Aldape, Kenneth D., DeMonte, Franco, Sulman, Erik P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882319/ https://www.ncbi.nlm.nih.gov/pubmed/29662628 http://dx.doi.org/10.18632/oncotarget.24498 |
Ejemplares similares
-
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
por: Modrek, Aram S., et al.
Publicado: (2022) -
Surgical Resection of an Optic Nerve Sheath Meningioma: Relevance of Endoscopic Endonasal Approaches to the Optic Canal
por: Hunt, Patrick J., et al.
Publicado: (2017) -
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting
por: Balasubramaniyan, Veerakumar, et al.
Publicado: (2015) -
Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2018) -
FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients
por: Zlotnick, D., et al.
Publicado: (2010)